Figma's share price sits at US$22.51, a level that a discounted cash flow model values at roughly $27.25 per share — implying the stock is trading about 17.4% below that intrinsic estimate even as the price has swung sharply: down roughly 4% over the past week, up about 15.9% over the last month and down roughly 40.1% year to date.
The valuation picture grows more pointed when compared with sales multiples. Figma trades at a price-to-sales ratio of 10.24x, far above the software industry average of 3.79x and the peer group average of 6.33x; Simply Wall St’s own Fair Ratio for the company is 9.22x and its broader valuation framework gave Figma a value score of 1 out of 6.
The DCF that produces the $27.25 intrinsic target is rooted in cash-flow projections that show free cash flow of about $235.1 million for the latest twelve months, a short-term dip to $154.8 million in 2026, then rising to $500.7 million by 2029 and ultimately to $1,177.4 million in 2035. At the same time, analysts and modelers point to product developments that could lift revenue — Simply Wall St highlights AI-driven products such as Figma Make, MCP and Figma Weave as meaningful contributors to the company’s revenue trajectory.
That combination — a DCF suggesting a modest discount to intrinsic value alongside a sales multiple well above industry and peer norms — creates the clearest friction in the math investors must reconcile. The DCF’s forward cash-flow path requires sustained growth to justify both a move to the model’s intrinsic value and the premium multiple the market currently assigns; yet Simply Wall St’s low value score signals skepticism about near-term execution relative to the price investors are paying.
Market moves earlier in the year reflect that split view. A separate Simply Wall St note from 2026 recorded the stock trading at $20.49 and a year-to-date drop of 45.5%, underscoring how volatile the share price has been around differing expectations for growth and profitability.
The practical implication is straightforward: the recent 15.9% month gain and the DCF discount leave room to argue the shares are attractively priced on an intrinsic basis, but the 10.24x price-to-sales multiple keeps the stock on the expensive side relative to software peers. The open question investors must now resolve is whether Figma’s revenue and free-cash-flow trajectory will accelerate quickly enough — through product adoption, AI revenue contribution or margin improvement — to validate a double-digit sales multiple, or whether the market will re-rate the shares down to better align price with nearer-term cash flows.
